Pharma Journalist -

Bristol Myers Squibb announced that the European Commission (EC) has approved the fixed-dose combination of Opdualag (nivolumab and relatlimab) for the first-line treatment of advanced…
Read More...

NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co., Ltd. announced that they have entered into a conditional exclusive license agreement for NeuroBo to develop and commercialize DA-1241…
Read More...

Caladrius Biosciences, Inc. and Cend Therapeutics, Inc. announced that the proposed merger of the two companies has closed following the approval of Caladrius’ stockholders on September…
Read More...

Gilead Sciences, Inc. announced updates to the World Health Organization’s (WHO) Therapeutics and COVID-19: living guideline, which now conditionally recommends Veklury (remdesivir) for…
Read More...

SAE Media Group reports: The Biosensors for Medical Wearables Conference will welcome Pfizer, AstraZeneca, DiMe, MedRhythms and many more biotech companies Join SAE Media Group at…
Read More...

Avicanna Inc., a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, is pleased to announce that it…
Read More...

Mallinckrodt plc announced that the U.S. Food and Drug Administration (FDA) approved Terlivaz (terlipressin) for injection. Terlivaz is the first and only FDA-approved product indicated…
Read More...

Oxford Biomedica plc announces that its subsidiary Oxford Biomedica Solutions LLC has signed an agreement with a new undisclosed, U.S. based, private biotechnology company. The…
Read More...

BriaCell Therapeutics Corp. announces that it has signed an agreement with Caris Life Sciences (Caris). “Our goal is to develop immunotherapies that are personalized for each patient,…
Read More...

The U.S. Food and Drug Administration and the National Institutes of Health (NIH) announced the launch of the Critical Path for Rare Neurodegenerative Diseases (CP-RND) – a…
Read More...